Made in IBM Labs: New Data Sharing Technology

IBMIBM, in collaboration with the Nuclear Threat Initiative's (NTI) Global Health and Security Initiative and the Middle East Consortium on Infectious Disease Surveillance (MECIDS), has created a unique technology that standardizes the method of sharing health information and automates the analysis of infectious disease outbreaks, in order to help contain diseases and minimize their impact.

The secure, Web-based portal system, the Public Health Information Affinity Domain (PHIAD), is being deployed in the Middle East first, and the partners are pushing for international deployment.

This award-winning technology provides public health organizations with the right decision-making tools to implement a fast, effective response to infectious disease outbreaks – even across geographic and political boundaries. PHIAD uses near-real time information to facilitate fast response and enables the secure exchange of data on both national and international levels with appropriate protection of privacy at all levels.

With PHIAD, researchers at IBM’s Almaden and Haifa labs have virtually eliminated the time-consuming, tedious tasks common in the public health community by creating an electronic platform that allows them to focus on critical tasks such as detecting emerging public health trends, pinpointing potential outbreaks and performing sophisticated analysis.

"This collaboration writes the newest chapter in a story of healthcare information technology innovation — innovation that progressively tackles head-on the lack of integration and communication between key players in the healthcare industry worldwide," said Dan Pelino, General Manager, IBM Healthcare & Life Sciences Industry. "Built upon the same, open-standards-based Health Information Exchange architecture that increasingly enables the use of electronic health records around the world, this new technology will take transformation higher, improving critical health information sharing between nations in an increasingly global economy - and helping the world’s healthcare community to focus on prevention, wellness and the safety of patients and populations at large."

The rise of global economies and the increased reliance on global transportation and trade increases the risk of worldwide disaster due to infectious disease. Disease requirement reporting is required by law in most countries and under the International Health Regulations (IHR). The new IHR requires all countries to report any infectious disease outbreak of international significance. Today, most reporting is done via fax, spreadsheet or phone calls. Public health needs near-real time information to respond quickly to emerging infectious disease. The biggest technical challenge is the lack of interoperability and use of standards and uniform coding systems. The current methods of sharing information are slow, unwieldy and in many cases almost nonexistent.

NTI's Global Health and Security Initiative supported the development of an infectious disease surveillance system in the Middle East among Israel, Jordan and the Palestinian Authority. The partnership was up and running in the region when the first outbreak of bird flu was detected. MECIDS enabled rapid communication and coordination of efforts to contain the spread of the disease. The partnership has continued to function and grow, despite political tensions in the area. MECIDS participated in the development of PHIAD and will be an early adopter of the technology.

Currently, MECIDS members exchange information mostly on paper. By moving to a standards-based model of secure electronic information exchange that integrates public health reporting with the creation of clinical records, members can easily share and exchange key data to monitor and respond to potential outbreaks. The collected data can easily feed into IBM’s pandemic disease modeling system, Spatio Temporal Epidemiological Modeler, which enables public health officials to visualize outbreak prevention strategies and perform forecast modeling.

"Nuclear Threat Initiative’s Global Health and Security Initiative is working in some of the most complicated regions of the world to help develop regional disease surveillance networks such as MECIDS that can be the building blocks for improving the quality and effectiveness of global disease surveillance," said Terence Taylor, Nuclear Threat Initiative's Vice President for Global Health and Security. "IBM's PHIAD system will enhance the existing regional collaboration at several levels and allow health professionals to stay a step ahead of potentially dangerous disease outbreaks."

The MECIDS project will use SNOMED CT® (Systematized Nomenclature of Medicine-Clinical Terms), an international standard that provides a core terminology for electronic health records. The International Health Terminology Standards Development Organisation (IHTSDO) has waived license fees for use of SNOMED CT in this project on humanitarian grounds. This contribution enables MECIDS countries to standardize public health data so it can be used and consistently interpreted across borders and different health organizations.

PHIAD is available on IBM alphaWorks.

For more information about IBM, please visit www.ibm.com.

For more information about NTI's Global Health and Security Initiative and MECIDS, please visit www.ghsi.org.

Related news articles:

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...